<DOC>
	<DOCNO>NCT00833755</DOCNO>
	<brief_summary>The purpose study compare pain threshold , pain tolerance , wind , measure QST , single dose ketamine infusion two clinical condition : chronic pain patient opioid therapy chronic pain patient without opioid therapy .</brief_summary>
	<brief_title>Effect Ketamine Opioid-Induced Hyperalgesia</brief_title>
	<detailed_description>We hypothesize : 1 . Chronic pain patient chronic opioids would lower pain threshold low pain tolerance compare opioid na√Øve patient ( patient chronic pain non-opioids treatment ) . , measure QST non-affected neutral limb ; 2 . Chronic pain patient chronic opioids would increase response painful stimulation , call `` windup '' demonstrate QST ; 3 . Both `` wind-up '' alter pain threshold tolerance would indicative presence opioid-induced hyperalgesia ; 4 . Intravenous ketamine , NMDA receptor antagonist , could use differentiate opioid-induced hyperalgesia opioid tolerance .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Hyperalgesia</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Inclusion Criteria Group 1 1 . Subject age 18 65 year . 2 . Subject chronic pain condition least three month . This requirement set order avoid clinical uncertainty unstable pain condition minimize study variation . Subjects VAS pain score 4 time study . 3 . Subject chronic opioid treatment regimen ( e.g. , morphine , fentanyl , oxycodone , methadone , hydromorphone , hydrocodone ) least three month . There change type amount opioid dose least one month . Only patient minimal daily dose least 60 mg morphine equianalgesic dose include . Inclusion Criteria Group 2 1 . Subject meet criteria # 1 &amp; # 2 list Group 1 . 2 . Subject opioid regimen last three month . Exclusion Criteria group : 1 . Subject altered sensation skin site QST ( one upper extremity ) . 2 . Subject scar tissue acute injury skin site QST . 3 . Subject neurological disease condition cause upper extremity generalize polyneuropathy , diabetic neuropathy , alcoholic neuropathy , AIDS neuropathy , multiple sclerosis , amyotrophic lateral sclerosis , poststroke residual neurological deficit . 4 . Subject diagnosis renal liver failure . 5 . Subject diagnosis unstable angina , congestive heart failure , cardiac arrythmias myocardial infarction within 1 year . 6 . Subject allergic ketamine . 7 . Subject recent therapy may influence QST result , e.g. , neuroablative procedure involve upper extremity within sixmonths peripheral neurolytic block involve upper extremity within twomonths . 8 . Subject confirm diagnosis care psychiatrist major depression disorder , eat disorder ; alcohol drug dependence ; attention deficit hyperactivity disorder . Subject history confirm diagnosis bipolar disorder , schizophrenia , anxiety disorder psychotic disorder 9 . Subject test positive drug urine screen test . 10 . Subject pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Pain</keyword>
	<keyword>Chronic pain</keyword>
	<keyword>Opioid induce hyperalgesia</keyword>
	<keyword>Opioid therapy</keyword>
</DOC>